HUBBARD ROBERT GLENN 4

What Happened
Robert Glenn Hubbard, a non-management director of MetLife, received 678 shares on 2026-06-09 at an imputed price of $85.57 per share, a total value of $58,016. This was recorded as an acquisition/award (code A) and reflects an imputed reinvestment of dividends into deferred MetLife shares—not an open‑market purchase.

Key Details

• Transaction date: 2026-06-09; reported on Form 4 filed 2026-06-11 (timely filing).
• Price per share: $85.57; total value: $58,016.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: The shares were credited under the MetLife Deferred Compensation Plan for Non‑Management Directors (imputed reinvestment of dividends on deferred shares).
• Transaction type: A (award/grant/other acquisition) via dividend reinvestment — not a cash purchase or option exercise.

Context
Dividend reinvestments and deferred‑compensation credits for directors are routine and reflect plan mechanics rather than a direct market buy or sale. Such transactions are generally less indicative of a change in insider sentiment than outright purchases or sales.